23-09-2021 08:00
In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.
15-06-2021 20:43
SK Investment Vina III Pte., Ltd. has spent over VND34.5 billion ($1.5 million) to acquire 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.
09-06-2021 20:53
There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
16-12-2020 11:55
The Asian Development Bank (ADB) signed an $8 million loan with Imexpharm Corporation to help the company sustain its production of generic medicines, despite global supply disruptions caused by the COVID-19 pandemic.
01-06-2020 14:44
South Korean conglomerate SK Group has become a large shareholder of Imexpharm (IMP), adding to its considerable portfolio of shares in Vingroup, Masan, and PV Oil.
07-04-2020 19:06
A bit of a silver lining to the COVID-19 lockdown, major pharma firms expect to see visible growth in revenue this year.
24-02-2020 14:00
As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
05-09-2017 17:45
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth-biggest pharmaceutical firm, will consider scrapping the foreign ownership limit if this becomes a common trend.
29-07-2017 18:24
Imexpharm Pharmaceutical Joint Stock Company, Vietnam's fourth biggest pharmaceutical firm, will not extend the distribution contract with its foreign partner IMGSA Group in the future.
16-05-2016 08:00
While Vietnam’s third-largest domestic drug maker Domesco has agreed to remove the foreign ownership ratio ceiling, other leading domestic pharmaceutical firms, including Imexpharm and Hau Giang Pharmaceutical JSC, have again announced no change to the cap.
14-05-2013 10:29
Locally-owned pharmaceutical maker Imexpharm Corporation has successfully defended itself after the Government Inspectorate accused it of violating medicine material trading regulations - but the case still damaged its reputation, company officers say.